Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2065

1.

Genome-wide expression quantitative trait loci studies facilitate isolation of causal genes controlling panicle structure.

Wang F, Yano K, Nagamatsu S, Inari-Ikeda M, Koketsu E, Hirano K, Aya K, Matsuoka M.

Plant J. 2020 Feb 18. doi: 10.1111/tpj.14726. [Epub ahead of print]

PMID:
32072700
2.

Changes in Duration and Intensity of the World's Top-Level Badminton Matches: A Consideration of the Increased Acute Injuries among Elite Women's Singles Players.

Iizuka T, Hirano K, Atomi T, Shimizu M, Atomi Y.

Sports (Basel). 2020 Feb 8;8(2). pii: E19. doi: 10.3390/sports8020019.

3.

In Vitro Evaluation of Different Prebiotics on the Modulation of Gut Microbiota Composition and Function in Morbid Obese and Normal-Weight Subjects.

Nogacka AM, Salazar N, Arboleya S, Ruas-Madiedo P, Mancabelli L, Suarez A, Martinez-Faedo C, Ventura M, Tochio T, Hirano K, Endo A, G de Los Reyes-Gavilán C, Gueimonde M.

Int J Mol Sci. 2020 Jan 30;21(3). pii: E906. doi: 10.3390/ijms21030906.

4.

Usefulness of a Guide Extension Catheter in Endovascular Therapy of Infrapopliteal Lesions.

Fukagawa T, Hirano K, Yamawaki M, Araki M, Kobayashi N, Mori S, Sakamoto Y, Tsutsumi M, Honda Y, Makino K, Mizusawa M, Shirai S, Ito Y.

Ann Vasc Surg. 2020 Feb 1. pii: S0890-5096(20)30128-X. doi: 10.1016/j.avsg.2020.01.086. [Epub ahead of print]

PMID:
32018022
5.

Metachronous rupture of a residual pancreaticoduodenal aneurysm after release of the median arcuate ligament: a case report.

Kimura N, Matsui K, Shibuya K, Yoshioka I, Naruto N, Hoshino Y, Mori K, Hirano K, Watanabe T, Hojo S, Sawada S, Okumura T, Nagata T, Noguchi K, Fujii T.

Surg Case Rep. 2020 Feb 3;6(1):34. doi: 10.1186/s40792-020-0784-5.

6.

Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab.

Morita M, Tamiya M, Fujimoto D, Tamiya A, Suzuki H, Hirano K, Fukuda Y, Yokoyama T, Kominami R, Kanazu M, Uchida J, Hara S, Yamashita S, Tomioka H.

BMC Cancer. 2020 Feb 3;20(1):93. doi: 10.1186/s12885-020-6582-4.

7.

Targeting of plasminogen activator inhibitor-1 activity promotes elimination of chronic myeloid leukemia stem cells.

Yahata T, Ibrahim AA, Hirano KI, Muguruma Y, Naka K, Hozumi K, Vaughan DE, Miyata T, Ando K.

Haematologica. 2020 Jan 30. pii: haematol.2019.230227. doi: 10.3324/haematol.2019.230227. [Epub ahead of print]

8.

Delta-like 1 and Delta-like 4 differently require their extracellular domains for triggering Notch signaling in mice.

Hirano KI, Suganami A, Tamura Y, Yagita H, Habu S, Kitagawa M, Sato T, Hozumi K.

Elife. 2020 Jan 16;9. pii: e50979. doi: 10.7554/eLife.50979.

9.

A new serine protease family with elastase activity is produced by Streptomyces bacteria.

Fujii T, Fukano K, Hirano K, Mimura A, Terauchi M, Etoh SI, Iida A.

Microbiology. 2020 Jan 2. doi: 10.1099/mic.0.000880. [Epub ahead of print]

PMID:
31896394
10.

Taking another's perspective promotes right parieto-frontal activity that reflects open-minded thought.

Miura N, Sugiura M, Nozawa T, Yamamoto Y, Sasaki Y, Hamamoto Y, Yamazaki S, Hirano K, Takahashi M, Kawashima R.

Soc Neurosci. 2019 Dec 30:1-14. doi: 10.1080/17470919.2019.1710249. [Epub ahead of print]

PMID:
31888419
11.

A historical case of primary triglyceride deposit cardiomyovasculopathy.

Tanaka M, Ikeda Y, Li M, Zaima N, Kawahara Y, Watanabe K, Inaba T, Kobayashi K, Noguchi H, Yamada S, Hao H, Hirano KI.

Pathol Int. 2020 Jan;70(1):58-61. doi: 10.1111/pin.12884. Epub 2019 Dec 18. No abstract available.

PMID:
31854040
12.

Toward Easy and Rapid Bronchial Occlusion With an Endobronchial Watanabe Spigot: A New Technique Using a Guide Sheath and Curette.

Mizumori Y, Nakahara Y, Hirata N, Hiraoka R, Kominami R, Hirano K, Hanaoka K, Katsuda R, Miyake K, Kawamura T.

J Bronchology Interv Pulmonol. 2019 Dec 16. doi: 10.1097/LBR.0000000000000642. [Epub ahead of print]

PMID:
31851015
13.

Clinical efficacy of optical coherence tomography-guided versus intravascular ultrasound-guided rotational atherectomy for calcified coronary lesion.

Kobayashi N, Ito Y, Yamawaki M, Araki M, Obokata M, Sakamoto Y, Mori S, Tsutsumi M, Honda Y, Makino K, Shirai S, Mizusawa M, Hirano K.

EuroIntervention. 2019 Dec 17. pii: EIJ-D-19-00725. doi: 10.4244/EIJ-D-19-00725. [Epub ahead of print]

14.

The ARAHKEY technique: A novel method for the management of access site bleeding during percutaneous transfemoral transcatheter aortic valve replacement.

Honda Y, Araki M, Yamawaki M, Hirano K, Kobayashi N, Sakamoto Y, Mori S, Tsutsumi M, Makino K, Ito Y.

Catheter Cardiovasc Interv. 2019 Dec 9. doi: 10.1002/ccd.28610. [Epub ahead of print]

PMID:
31815366
15.

Characterization of the metastatic potential of the floating cell component of MIA PaCa-2, a human pancreatic cancer cell line.

Sasaki N, Gomi F, Hasegawa F, Hirano K, Fujiwara M, Toyoda M, Ishiwata T.

Biochem Biophys Res Commun. 2020 Feb 19;522(4):881-888. doi: 10.1016/j.bbrc.2019.11.120. Epub 2019 Dec 2.

PMID:
31806369
16.

Association between metastatic sites and first-line pembrolizumab treatment outcome for advanced non-small cell lung cancer with high PD-L1 expression: a retrospective multicenter cohort study.

Kawachi H, Tamiya M, Tamiya A, Ishii S, Hirano K, Matsumoto H, Fukuda Y, Yokoyama T, Kominami R, Fujimoto D, Hosoya K, Suzuki H, Hirashima T, Kanazu M, Sawa N, Uchida J, Morita M, Makio T, Hara S, Kumagai T.

Invest New Drugs. 2020 Feb;38(1):211-218. doi: 10.1007/s10637-019-00882-5. Epub 2019 Nov 30.

PMID:
31784866
17.

Expanding a polarized synchrotron beam for full-field x-ray fluorescence imaging.

Zhao W, Hirano K, Sakurai K.

Rev Sci Instrum. 2019 Nov 1;90(11):113704. doi: 10.1063/1.5115421.

PMID:
31779452
18.

Undifferentiated high-grade pleomorphic sarcoma of the mediastinum.

Nakayama T, Numasawa Y, Hashimoto K, Hirano K.

Oxf Med Case Reports. 2019 Sep 28;2019(9):omz086. doi: 10.1093/omcr/omz086. eCollection 2019 Sep. No abstract available.

19.

Stress fractures of the lateral tibial plateau after open wedge high tibial osteotomy could be delayed type III lateral hinge fractures.

Yokoyama M, Nakamura Y, Doi H, Onishi T, Hirano K, Doi M.

Asia Pac J Sports Med Arthrosc Rehabil Technol. 2019 Nov 4;18:23-27. doi: 10.1016/j.asmart.2019.10.001. eCollection 2019 Oct.

20.

Detection of the oil-producing microalga Botryococcus braunii in natural freshwater environments by targeting the hydrocarbon biosynthesis gene SSL-3.

Hirano K, Hara T, Ardianor, Nugroho RA, Segah H, Takayama N, Sulmin G, Komai Y, Okada S, Kawamura K.

Sci Rep. 2019 Nov 18;9(1):16974. doi: 10.1038/s41598-019-53619-y.

21.

A Direct, Chemo-, and Regioselective Cross-Coupling Reaction of Arenes via Sequential Directed ortho Cuprations and Oxidation.

Tezuka N, Hirano K, Uchiyama M.

Org Lett. 2019 Dec 6;21(23):9536-9540. doi: 10.1021/acs.orglett.9b03719. Epub 2019 Nov 18.

PMID:
31738063
22.

Successful treatment of non-IgM lymphoplasmacytic lymphoma by bortezomib-containing regimen: case reports and review of literature.

Ito K, Nishiyama R, Hirano K, Yamada K, Sekiguchi N.

Blood Res. 2019 Sep;54(3):236-240. doi: 10.5045/br.2019.54.3.236. Epub 2019 Sep 25. No abstract available.

23.

Asymmetric aerobic oxidation of secondary alcohols catalyzed by poly(N-vinyl-2-pyrrolidone)-stabilized gold clusters modified with cyclodextrin derivatives.

Hirano K, Takano S, Tsukuda T.

Chem Commun (Camb). 2019 Dec 12;55(100):15033-15036. doi: 10.1039/c9cc06770a.

PMID:
31729494
24.

Risk factors for postoperative pneumonia after general and digestive surgery: a retrospective single-center study.

Baba H, Tokai R, Hirano K, Watanabe T, Shibuya K, Hashimoto I, Hojo S, Yoshioka I, Okumura T, Nagata T, Fujii T.

Surg Today. 2019 Nov 11. doi: 10.1007/s00595-019-01911-9. [Epub ahead of print]

PMID:
31712912
25.

Non-insulin-dependent Diabetes Mellitus Induced by Immune Checkpoint Inhibitor Therapy in an Insulinoma-associated Antigen-2 Autoantibody-positive Patient with Advanced Gastric Cancer.

Ohara N, Kobayashi M, Ikeda Y, Hoshi T, Morita S, Kanefuji T, Yagi K, Suda T, Takada T, Hasegawa G, Sato Y, Hirano K, Kosugi SI.

Intern Med. 2020 Feb 15;59(4):551-556. doi: 10.2169/internalmedicine.3208-19. Epub 2019 Nov 8.

26.

X-ray interference fringes from a weakly bent plane-parallel crystal with negative strain gradient.

Fukamachi T, Jongsukswat S, Ju D, Negishi R, Hirano K, Kawamura T.

Acta Crystallogr A Found Adv. 2019 Nov 1;75(Pt 6):842-850. doi: 10.1107/S2053273319011859. Epub 2019 Oct 7.

27.

Japanese Patients Treated in the IMPERIAL Randomized Trial Comparing Eluvia and Zilver PTX Stents.

Soga Y, Fujihara M, Iida O, Kawasaki D, Hirano K, Yokoi H, Miyamoto A, Kichikawa K, Nakamura M, Ohki T, Diaz-Cartelle J, Gray WA, Müller-Hülsbeck S.

Cardiovasc Intervent Radiol. 2020 Feb;43(2):215-222. doi: 10.1007/s00270-019-02355-x. Epub 2019 Nov 5.

PMID:
31690980
28.

Impact of the Frozen Elephant Trunk Technique on Total Aortic Arch Replacement.

Hirano K, Tokui T, Nakamura B, Inoue R, Inagaki M, Hirano R, Chino S, Maze Y, Kato N, Takao M.

Ann Vasc Surg. 2019 Oct 31. pii: S0890-5096(19)30930-6. doi: 10.1016/j.avsg.2019.10.075. [Epub ahead of print]

PMID:
31678125
29.

Refractive error and biometrics of anterior segment of eyes of healthy young university students in Japan.

Kato K, Kondo M, Takeuchi M, Hirano K.

Sci Rep. 2019 Oct 25;9(1):15337. doi: 10.1038/s41598-019-51920-4.

30.

Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab-Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer.

Tsuchiya-Kawano Y, Sasaki T, Yamaguchi H, Hirano K, Horiike A, Satouchi M, Hosokawa S, Morinaga R, Komiya K, Inoue K, Fujita Y, Toyozawa R, Kimura T, Takahashi K, Nishikawa K, Kishimoto J, Nakanishi Y, Okamoto I.

Oncologist. 2019 Oct 24. pii: theoncologist.2019-0746. doi: 10.1634/theoncologist.2019-0746. [Epub ahead of print]

31.

Independent predictors of loss of primary patency at 1 year after aortoiliac stent implantation.

Yamauchi Y, Takahara M, Iida O, Shintani Y, Sugano T, Yamamoto Y, Kawasaki D, Fujihara M, Soga Y, Hirano K, Yokoi H, Miyamoto A, Nakamura M; OMOTENASHI investigators.

Heart Vessels. 2019 Oct 23. doi: 10.1007/s00380-019-01524-9. [Epub ahead of print]

PMID:
31642981
32.

LacdiNAcylation of N-glycans in MDA-MB-231 human breast cancer cells results in changes in morphological appearance and adhesive properties of the cells.

Hirano K, Takada Y, Furukawa K.

Histochem Cell Biol. 2020 Jan;153(1):17-26. doi: 10.1007/s00418-019-01822-3. Epub 2019 Oct 12.

PMID:
31606752
33.

In vitro assembly and cellulolytic activity of a β-glucosidase-integrated cellulosome complex.

Hirano K, Saito T, Shinoda S, Haruki M, Hirano N.

FEMS Microbiol Lett. 2019 Sep 1;366(17). pii: fnz209. doi: 10.1093/femsle/fnz209.

PMID:
31584652
34.

GWAS with principal component analysis identifies a gene comprehensively controlling rice architecture.

Yano K, Morinaka Y, Wang F, Huang P, Takehara S, Hirai T, Ito A, Koketsu E, Kawamura M, Kotake K, Yoshida S, Endo M, Tamiya G, Kitano H, Ueguchi-Tanaka M, Hirano K, Matsuoka M.

Proc Natl Acad Sci U S A. 2019 Oct 15;116(42):21262-21267. doi: 10.1073/pnas.1904964116. Epub 2019 Sep 30.

35.

Clinical Impact and Predictors of the Slow-Flow Phenomenon after Endovascular Treatment of Infrapopliteal Lesions Using the Crosser Catheter in Patients with Critical Limb Ischemia.

Kobayashi N, Hirano K, Yamawaki M, Araki M, Sakai T, Sakamoto Y, Mori S, Tsutsumi M, Nauchi M, Honda Y, Makino K, Shirai S, Sugizaki Y, Fukagawa T, Kishida T, Ito Y.

J Vasc Interv Radiol. 2020 Jan;31(1):141-149. doi: 10.1016/j.jvir.2019.05.034. Epub 2019 Sep 18.

PMID:
31542277
36.

Management of Postoperative Inflammation and Dry Eye After Cataract Surgery.

Kato K, Miyake K, Hirano K, Kondo M.

Cornea. 2019 Nov;38 Suppl 1:S25-S33. doi: 10.1097/ICO.0000000000002125. Review.

PMID:
31498249
37.

Comparison of urea clear space and eKt/V during online hemodiafiltration.

Nakayama T, Kawauchi R, Hirano K.

Clin Nephrol. 2019 Nov;92(5):276-278. doi: 10.5414/CN109781. No abstract available.

PMID:
31496511
38.

Prior physical synchrony enhances rapport and inter-brain synchronization during subsequent educational communication.

Nozawa T, Sakaki K, Ikeda S, Jeong H, Yamazaki S, Kawata KHDS, Kawata NYDS, Sasaki Y, Kulason K, Hirano K, Miyake Y, Kawashima R.

Sci Rep. 2019 Sep 4;9(1):12747. doi: 10.1038/s41598-019-49257-z.

39.

Risk of undiagnosed coronary artery disease associated with infrapopliteal artery occlusion from a multicenter study.

Imaeda S, Kuno T, Hirano K, Kodaira M, Anzai H, Numasawa Y.

Heart Vessels. 2020 Mar;35(3):307-311. doi: 10.1007/s00380-019-01495-x. Epub 2019 Aug 31.

PMID:
31473802
40.

Insulin secretion improvement during steroid therapy for autoimmune pancreatitis according to the onset of diabetes mellitus.

Noguchi K, Nakai Y, Mizuno S, Isayama H, Hirano K, Kanai S, Nakamura T, Uchino R, Takahara N, Kogure H, Tada M, Koike K.

J Gastroenterol. 2020 Feb;55(2):198-204. doi: 10.1007/s00535-019-01615-4. Epub 2019 Aug 30.

PMID:
31471733
41.

Development of a simultaneous quantitation for short-, medium-, long-, and very long-chain fatty acids in human plasma by 2-nitrophenylhydrazine-derivatization and liquid chromatography-tandem mass spectrometry.

Chen Z, Gao Z, Wu Y, Shrestha R, Imai H, Uemura N, Hirano KI, Chiba H, Hui SP.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Sep 15;1126-1127:121771. doi: 10.1016/j.jchromb.2019.121771. Epub 2019 Aug 19.

PMID:
31465896
42.

A phase II study of low starting dose of afatinib as first-line treatment in patients with EGFR mutation-positive non-small-cell lung cancer (KTORG1402).

Yokoyama T, Yoshioka H, Fujimoto D, Demura Y, Hirano K, Kawai T, Kagami R, Washio Y, Ishida T, Kogo M, Tomii K, Okuno T, Akai M, Hirabayashi M, Nishimura T, Nakahara Y, Kim YH, Miyakoshi C, Yoshimura K, Hirai T; Kyoto Thoracic Oncology Research Group (KTORG).

Lung Cancer. 2019 Sep;135:175-180. doi: 10.1016/j.lungcan.2019.03.030. Epub 2019 Mar 28.

PMID:
31446992
43.

Neuroprotective effects of memantine via enhancement of autophagy.

Hirano K, Fujimaki M, Sasazawa Y, Yamaguchi A, Ishikawa KI, Miyamoto K, Souma S, Furuya N, Imamichi Y, Yamada D, Saya H, Akamatsu W, Saiki S, Hattori N.

Biochem Biophys Res Commun. 2019 Oct 8;518(1):161-170. doi: 10.1016/j.bbrc.2019.08.025. Epub 2019 Aug 17.

PMID:
31431260
44.

Helical assembly of a dithienogermole exhibiting switchable circularly polarized luminescence.

Hirano K, Ikeda T, Fujii N, Hirao T, Nakamura M, Adachi Y, Ohshita J, Haino T.

Chem Commun (Camb). 2019 Aug 29;55(71):10607-10610. doi: 10.1039/c9cc05253d.

PMID:
31424063
45.

Characterization of fructooligosaccharide-degrading enzymes in human commensal Bifidobacterium longum and Anaerostipes caccae.

Tanno H, Fujii T, Ose R, Hirano K, Tochio T, Endo A.

Biochem Biophys Res Commun. 2019 Oct 15;518(2):294-298. doi: 10.1016/j.bbrc.2019.08.049. Epub 2019 Aug 13.

PMID:
31420164
46.

Efficacy and safety of pembrolizumab as first-line therapy in advanced non-small cell lung cancer with at least 50% PD-L1 positivity: a multicenter retrospective cohort study (HOPE-001).

Tamiya M, Tamiya A, Hosoya K, Taniguchi Y, Yokoyama T, Fukuda Y, Hirano K, Matsumoto H, Kominami R, Suzuki H, Hirashima T, Uchida J, Morita M, Kanazu M, Sawa N, Kinoshita Y, Hara S, Kumagai T, Fujimoto D.

Invest New Drugs. 2019 Dec;37(6):1266-1273. doi: 10.1007/s10637-019-00843-y. Epub 2019 Aug 7.

PMID:
31392549
47.

Visualization of sequential conversion of human intermediately reprogrammed stem cells into iPS cells.

Teshigawara R, Hirano K, Nagata S, Huang D, Tada T.

Genes Cells. 2019 Oct;24(10):667-673. doi: 10.1111/gtc.12716. Epub 2019 Sep 1.

PMID:
31386786
48.

Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in Japan.

Edahiro R, Kanazu M, Kurebe H, Mori M, Fujimoto D, Taniguchi Y, Suzuki H, Hirano K, Yokoyama T, Morita M, Fukuda Y, Uchida J, Makio T, Tamiya M.

PLoS One. 2019 Jul 31;14(7):e0220570. doi: 10.1371/journal.pone.0220570. eCollection 2019.

49.

Impact of kestose supplementation on the healthy adult microbiota in in vitro fecal batch cultures.

Endo A, Hirano K, Ose R, Maeno S, Tochio T.

Anaerobe. 2019 Jul 19:102076. doi: 10.1016/j.anaerobe.2019.102076. [Epub ahead of print]

PMID:
31326442
50.

What is the most appropriate regimen for untreated Waldenström macroglobulinemia? - An updated analysis of rituximab and half-dose CHOP therapy and cost effectiveness.

Sekiguchi N, Hamano A, Kitagawa T, Ito K, Hirano K, Yamada K.

Blood Res. 2019 Jun;54(2):153-156. doi: 10.5045/br.2019.54.2.153. Epub 2019 Jun 25. No abstract available.

Supplemental Content

Loading ...
Support Center